Literature DB >> 3126290

Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics.

G M Grass1, J R Robinson.   

Abstract

Corneal penetration studies were conducted in unanesthetized albino rabbits using various organic compounds representing both polar and nonpolar species. Very low molecular weight compounds demonstrate rapid uptake into the aqueous humor despite the lipid-like barrier imposed by the corneal epithelium. Evidence that these compounds may have access to a diffusional channel for corneal transport is presented. In vitro permeability studies were also conducted in an effort to quantitate the corneal diffusion of compounds covering a range of molecular weights and partition coefficients; the results corresponded well with the results of in vivo experiments. Calculations of energies of activation, taken from Arrhenius plots, indicate that the diffusion of drug across the cornea may be by two different mechanisms that depend on the physical-chemical characteristics of the perfusant. One mechanism appears similar to drug movement in an aqueous environment and is characterized by an activation energy similar to that for diffusion in water. The other relates to the expected partitioning of a compound across cellular membranes represented by a relatively high activation energy for diffusion. For hyrdophilic compounds, the epithelium appears to be rate limiting to drug movement, whereas for hydrophobic compounds, the stroma is rate limiting. In the presence of calcium-chelating agents, glycerol demonstrated an increase in corneal penetration in vivo. This effect appears to be reversible at specific concentrations of chelator. In contrast, divalent cations reduced corneal penetration of glycerol. The known calcium chelator EDTA was shown to penetrate the cornea, conjunctiva, and iris/ciliary body from a topically applied dose. The implications of this observation pertain to toxicity effects when EDTA is incorporated into ocular drug products for stability purposes, or novel stratagems for improving ocular bioavailability of topically applied drugs are employed. The addition of calcium-chelating agents to in vivo mounted corneas demonstrated increases in permeability of the cornea to glycerol which were directly related to the concentration of chelating agent used. These results paralleled the findings of similar in vivo studies. The results of these studies are consistent with a currently proposed 'pore' model for the penetration of drugs through the cornea which demonstrates both a partition coefficient and molecular weight dependency on the permeability of the cornea to transported compounds.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3126290     DOI: 10.1002/jps.2600770103

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  23 in total

1.  A simple corneal perfusion chamber for drug penetration and toxicity studies.

Authors:  M A Thiel; N Morlet; D Schulz; H F Edelhauser; J K Dart; D J Coster; K A Williams
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  High molecular weight hyaluronan decreases oxidative DNA damage induced by EDTA in human corneal epithelial cells.

Authors:  J Ye; H Wu; Y Wu; C Wang; H Zhang; X Shi; J Yang
Journal:  Eye (Lond)       Date:  2012-05-18       Impact factor: 3.775

3.  New water-soluble pilocarpine derivatives with enhanced and sustained muscarinic activity.

Authors:  P Druzgala; D Winwood; M Drewniak-Deyrup; S Smith; N Bodor; J J Kaminski
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

4.  A novel approach to formulation factor of aceclofenac eye drops efficiency evaluation based on physicochemical characteristics of in vitro and in vivo permeation.

Authors:  Vivek Dave; Sarvesh Paliwal
Journal:  Saudi Pharm J       Date:  2013-03-30       Impact factor: 4.330

Review 5.  Ocular drug delivery. Pharmacokinetic considerations.

Authors:  R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

6.  A correlation of permeabilities for passively transported compounds in monkey and rabbit jejunum.

Authors:  G M Grass; S A Sweetana
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

7.  Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers.

Authors:  T L Ke; G Graff; J M Spellman; J M Yanni
Journal:  Inflammation       Date:  2000-08       Impact factor: 4.092

8.  Entrapment of ketorolac tromethamine in polymeric vehicle for controlled drug delivery.

Authors:  S K Paliwal; Rajani Chauhan; Veena Sharma; D K Majumdar; S Paliwal
Journal:  Indian J Pharm Sci       Date:  2009-11       Impact factor: 0.975

9.  The relative potencies of cholinomimetics and muscarinic antagonists on the rat iris in vivo: effects of pH on potency of pirenzepine and telenzepine.

Authors:  J J Hagan; B van der Heijden; C L Broekkamp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

10.  A method to study drug concentration-depth profiles in tissues: mitomycin C in dog bladder wall.

Authors:  M G Wientjes; J T Dalton; R A Badalament; B M Dasani; J R Drago; J L Au
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.